NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reveals Plan to Change Company Name to Availa Bio Upon Completion of Cannaworx, SkinScience Transactions
Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its plan to change the company’s name to Availa Bio upon completion of the acquisitions and merger of Cannaworx, Inc. and SkinScience Labs, Inc. The three companies will function as synergistic divisions within the combined “Availa Bio” entity, which will focus on optimizing bioavailability, absorption, quality and performance of human, animal and agricultural products. “PBI’s UST platform offers the potential to deliver an extraordinary breakthrough in creating unique, high quality nanoemulsions of oil in water. A vast range of personal care and consumption products, including nutraceuticals, cosmetics, pharmaceuticals, food & beverages, all face the perplexing challenge of getting active oil-based nutrients or therapeutic ingredients to become easily absorbable and effective in the water-based biology of our bodies. The opportunity to combine our strong engineering and biotech capabilities with two companies that already provide product innovation and brand leadership in diverse consumer product areas is very exciting and allows us to clearly move the identity and market focus of the combined companies from science platforms to the value delivery of availability and performance of active ingredients in final products,” Pressure BioScience president and CEO Richard T. Schumacher stated in the news release.
In addition, the company was recently highlighted in a Small Caps Daily article discussing the recently announced acquisitions (http://nnw.fm/eugP7). Among other highlights, the article discusses how the company will advance following the acquisitions of Cannaworx, a company with a strong and diversified portfolio of U.S. hemp-derived CBD products and intellectual property, and the SkinScience(R) brand, a profitable and highly renowned company within the cosmetics space. Both the letter of intent (“LOI”) between Cannaworx, Inc. and SkinScience Labs, and the letter of intent between PBIO and Cannaworx, Inc. are subject to certain closing conditions, including satisfaction of all due diligence and acquisition financing.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its plan to change the company’s name to Availa Bio upon completion of the acquisitions and merger of Cannaworx, Inc. and SkinScience Labs, Inc. The three companies will function as synergistic divisions within the combined “Availa Bio” entity, which will focus on optimizing bioavailability, absorption, quality and performance of human, animal and agricultural products. “PBI’s UST platform offers the potential to deliver an extraordinary breakthrough in creating unique, high quality nanoemulsions of oil in water. A vast range of personal care and consumption products, including nutraceuticals, cosmetics, pharmaceuticals, food & beverages, all face the perplexing challenge of getting active oil-based nutrients or therapeutic ingredients to become easily absorbable and effective in the water-based biology of our bodies. The opportunity to combine our strong engineering and biotech capabilities with two companies that already provide product innovation and brand leadership in diverse consumer product areas is very exciting and allows us to clearly move the identity and market focus of the combined companies from science platforms to the value delivery of availability and performance of active ingredients in final products,” Pressure BioScience president and CEO Richard T. Schumacher stated in the news release.
In addition, the company was recently highlighted in a Small Caps Daily article discussing the recently announced acquisitions (http://nnw.fm/eugP7). Among other highlights, the article discusses how the company will advance following the acquisitions of Cannaworx, a company with a strong and diversified portfolio of U.S. hemp-derived CBD products and intellectual property, and the SkinScience(R) brand, a profitable and highly renowned company within the cosmetics space. Both the letter of intent (“LOI”) between Cannaworx, Inc. and SkinScience Labs, and the letter of intent between PBIO and Cannaworx, Inc. are subject to certain closing conditions, including satisfaction of all due diligence and acquisition financing.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
